Stock Track | Baxter Plunges 8.85% in Pre-market on Earnings Miss, Net Loss and Weak Guidance
Stock Track
Feb 12
Baxter International's stock plummeted 8.85% in pre-market trading following the release of its fourth-quarter 2025 financial results.
The medical device company reported a significant miss on adjusted earnings per share, posting $0.36 compared to the Ibes estimate of $0.54. More concerning was the reported net loss of $1,128 million for the quarter.
While the company's revenue of $2,974 million exceeded estimates of $2,824 million, the weak bottom-line performance combined with a tepid full-year revenue growth outlook of 0-1% prompted the sharp sell-off.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.